BACKGROUND: The study was conducted to determine whether the phosphodiesterase (PDE) 3 inhibitor ORG 9935 prevents the resumption of meiosis in primate oocytes during natural menstrual cycles. STUDY DESIGN: Regularly cycling adult female macaques (n=8) were followed during the follicular phase and then started on a 2-day treatment regimen of human recombinant gonadotropins to control the timing of ovulation. Monkeys received no further treatment (controls) or ORG 9935. Oocytes were recovered by laparoscopic follicle aspiration 27 h after an ovulatory stimulus, cultured in vitro in the absence of inhibitor and inseminated. The primary outcome was the meiotic stage of the oocyte. RESULTS: In six ORG 9935 cycles, five of the recovered oocytes were germinal vesicle (GV)-intact, and one exhibited GV breakdown (GVBD). In contrast, all three oocytes that recovered during control cycles were GVBD (p<.05). None of the ORG 9935-treated oocytes underwent fertilization compared with 2/3 (67%) from controls. CONCLUSIONS: These results demonstrate that ORG 9935 blocks resumption of meiosis in the naturally selected dominant follicle in primates and suggest that PDE3 inhibitors have potential clinical use as contraceptives in women.
BACKGROUND: The study was conducted to determine whether the phosphodiesterase (PDE) 3 inhibitor ORG 9935 prevents the resumption of meiosis in primate oocytes during natural menstrual cycles. STUDY DESIGN: Regularly cycling adult female macaques (n=8) were followed during the follicular phase and then started on a 2-day treatment regimen of human recombinant gonadotropins to control the timing of ovulation. Monkeys received no further treatment (controls) or ORG 9935. Oocytes were recovered by laparoscopic follicle aspiration 27 h after an ovulatory stimulus, cultured in vitro in the absence of inhibitor and inseminated. The primary outcome was the meiotic stage of the oocyte. RESULTS: In six ORG 9935 cycles, five of the recovered oocytes were germinal vesicle (GV)-intact, and one exhibited GV breakdown (GVBD). In contrast, all three oocytes that recovered during control cycles were GVBD (p<.05). None of the ORG 9935-treated oocytes underwent fertilization compared with 2/3 (67%) from controls. CONCLUSIONS: These results demonstrate that ORG 9935 blocks resumption of meiosis in the naturally selected dominant follicle in primates and suggest that PDE3 inhibitors have potential clinical use as contraceptives in women.
Authors: Jeffrey T Jensen; Jessica E Stanley; Mary B Zelinski; Richard L Stouffer; Darla Jacob; John Fanton Journal: Fertil Steril Date: 2007-01-25 Impact factor: 7.329
Authors: A Wiersma; B Hirsch; A Tsafriri; R G Hanssen; M Van de Kant; H J Kloosterboer; M Conti; A J Hsueh Journal: J Clin Invest Date: 1998-08-01 Impact factor: 14.808
Authors: M B Zelinski-Wooten; J S Hutchison; I Trinchard-Lugan; D L Hess; D P Wolf; R L Stouffer Journal: Hum Reprod Date: 1997-09 Impact factor: 6.918
Authors: Jeffrey T Jensen; Mary B Zelinski-Wooten; Kristine M Schwinof; Jessica E Vance; Richard L Stouffer Journal: Contraception Date: 2005-01 Impact factor: 3.375
Authors: Leen Vanhoutte; Petra De Sutter; Daniela Nogueira; Jan Gerris; Marc Dhont; Josiane Van der Elst Journal: Hum Reprod Date: 2007-02-15 Impact factor: 6.918
Authors: Carol B Hanna; Shan Yao; Cathy M Ramsey; Jon D Hennebold; Mary B Zelinski; Jeffrey T Jensen Journal: Contraception Date: 2015-01-30 Impact factor: 3.375
Authors: Michael Feichtinger; Eytan R Barnea; Atunga Nyachieo; Mats Brännström; S Samuel Kim Journal: J Assist Reprod Genet Date: 2017-11-11 Impact factor: 3.412
Authors: Maxime Sasseville; Firas K Albuz; Nancy Côté; Christine Guillemette; Robert B Gilchrist; François J Richard Journal: Biol Reprod Date: 2009-04-08 Impact factor: 4.285